Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial
Crossref DOI link: https://doi.org/10.1186/s13014-017-0893-x
Published Online: 2017-09-22
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
De Wolf, Katrien
Rottey, Sylvie
Vermaelen, Karim
Decaestecker, Karel
Sundahl, Nora
De Lobel, Lizzy
Goetghebeur, Els
De Meerleer, Gert
Lumen, Nicolaas
Fonteyne, Valérie
De Maeseneer, Daan
Ost, Piet
Funding for this research was provided by:
Stichting Tegen Kanker
Novartis
